1834 Investment Advisors Co. Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

1834 Investment Advisors Co. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,256 shares of the healthcare conglomerate's stock after selling 1,861 shares during the quarter. 1834 Investment Advisors Co.'s holdings in UnitedHealth Group were worth $6,581,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter valued at $27,000. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate's stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the second quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after purchasing an additional 32 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Thursday, October 17th. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. Finally, Cantor Fitzgerald upped their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $615.53.

UnitedHealth Group Stock Up 5.3 %

Shares of UNH stock traded up $29.78 during trading hours on Wednesday, reaching $596.81. 4,554,903 shares of the stock were exchanged, compared to its average volume of 3,890,544. The firm has a market capitalization of $551.11 billion, a P/E ratio of 39.00, a P/E/G ratio of 1.64 and a beta of 0.58. The business's fifty day moving average is $580.96 and its two-hundred day moving average is $543.36. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the company earned $6.56 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group's payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.